Direct-to-store model (delivering drugs directly to each retailer’s stores) of distributors are increasingly becoming more popular among retailers (represents 93% of sales in 2017, up from 74% in 2007 ...

Boothbay Fund Management recently bought 6,688 shares of CVS Health, adding to growing hedge fund interest. Wall Street ...

NEW DELHI – On April 22, the International Monetary Fund (IMF) revised down its economic growth forecast for India ... supported by strong private consumption, especially in rural areas.

CVS stock has an attractive yield and earnings expansion. That makes it worth a look for investors seeking growth and income.

Pedersen and Maggie Fick COPENHAGEN/LONDON (Reuters) -Obesity drugmaker Novo Nordisk cut its sales forecasts on Wednesday for ...

Activist investor Glenview Capital said on Tuesday it had reduced its holdings in CVS Health following the insurer's "healthy ...

Cigna Group on Friday reported a $1.3 billion profit for the first quarter of 2025, a sharp turnaround from a year-earlier ...

CVS Health Corp. reported a strong start to 2025, with first-quarter revenue climbing 7%, driven by growth across all business segments.

Cigna posts strong Q1 results with rising sales at Evernorth and Cigna Healthcare; raises 2025 EPS outlook to $29.60 amid ...

CVS Health posted impressive Q1 2025 results with jumps in revenue, net income, and sales, yet it still decided to rain on ...

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of ...

Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...